Scinopharm Taiwan, Ltd.(TW:1789)
NT$20.00-0.25 (-1.23%)
TW:1789
Scinopharm Taiwan, Ltd. financials statements
NT$20.00
At close:-0.25 (-1.23%)
Scinopharm Taiwan, Ltd. (1789) Financial Statements
Scinopharm Taiwan, Ltd. Financial Overview
Scinopharm Taiwan, Ltd.'s market cap is currently NT$16.01B. The company's EPS TTM is NT$0.05; its P/E ratio is 904.98; and it has a dividend yield of 1.45%. Scinopharm Taiwan, Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 3.16B | NT$ 3.41B | NT$ 3.19B | NT$ 3.26B | NT$ 2.76B |
| Gross Profit | NT$ 1.10B | NT$ 1.30B | NT$ 1.22B | NT$ 1.25B | NT$ 1.28B |
| Operating Income | NT$ 108.91M | NT$ 322.71M | NT$ 314.49M | NT$ 405.63M | NT$ 288.74M |
| EBITDA | NT$ 673.97M | NT$ 909.38M | NT$ 819.15M | NT$ 885.34M | NT$ 690.37M |
| Net Income | NT$ 136.95M | NT$ 339.35M | NT$ 287.06M | NT$ 353.22M | NT$ 243.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 3.11B | NT$ 4.17B | NT$ 3.95B | NT$ 4.35B | NT$ 4.13B |
| Total Assets | NT$ 11.86B | NT$ 11.94B | NT$ 11.72B | NT$ 11.91B | NT$ 11.69B |
| Total Debt | NT$ 762.67M | NT$ 676.75M | NT$ 621.10M | NT$ 677.91M | NT$ 557.60M |
| Net Debt | NT$ -2.35B | NT$ -3.49B | NT$ -3.32B | NT$ -3.62B | NT$ -3.52B |
| Total Liabilities | NT$ 1.33B | NT$ 1.42B | NT$ 1.36B | NT$ 1.46B | NT$ 1.18B |
| Stockholders' Equity | NT$ 10.52B | NT$ 10.53B | NT$ 10.36B | NT$ 10.45B | NT$ 10.51B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 305.82M | NT$ 462.18M | NT$ -53.59M | NT$ 523.75M | NT$ 188.50M |
| Operating Cash Flow | NT$ 597.11M | NT$ 750.91M | NT$ 231.13M | NT$ 773.79M | NT$ 509.82M |
| Investing Cash Flow | NT$ -1.45B | NT$ -293.38M | NT$ -233.29M | NT$ -253.62M | NT$ -69.98M |
| Financing Cash Flow | NT$ -203.50M | NT$ -244.89M | NT$ -340.98M | NT$ -314.83M | NT$ -412.77M |
Currency in TWD
